Alkermes plans to present research results at the World Sleep Congress in Singapore.
2 reports, 2 independent
Updated Aug 25
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alkermes plans to present research results at the World Sleep Congress in Singapore.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Alkermes will present its research findings at the World Sleep Congress in Singapore.1 source
Alixorexton treatment showed significant improvements in wakefulness for Narcolepsy type 1.1 source
Keep exploring
The entities involved
-
Singapore
sovereign island country and city-state in maritime Southeast Asia
-
Alkermes
company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- PR NewswireAlkermes to Present Detailed Positive Results From Vibrance-1 Phase 2 Study Evaluating Alixorexton in Patients With Narcolepsy Type 1 at World Sleep 2025 – Results From Vibrance-1 to Be Shared in Thr
- BenzingaAlkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study Alkermes plc (NASDAQ:ALKS) on Monday released topline results from the randomized double-blind treatment period of the V